| Intuitive Surgical Hurt Performance of Top Ten Large-Cap Stocks | |
| | |
|
What Impacted the iShares US Medical Devices ETF on October 12? (Continued from Prior Part) Top ten large-cap stocks outperformed
The top ten stocks within the iShares Medical Devices ETF (IHI) by market cap outperformed the SPDR S&P 500 ETF (SPY) and IHI itself with an average return of 0.21%. SPY returned 0.09% and IHI returned 0.15% on October 12, 2015. The top ten includes stocks like Medtronic (MDT), Abbott Laboratories (ABT), and Thermo Fischer Scientific (TMO), which returned 0.55%, 0.75%, and 0.5%, respectively. The combined weight of the top ten large-cap stocks was 65.4% of IHI’s portfolio.
The above graph reflects the performance comparison of IHI’s top ten large-cap stocks with IHI and SPY on October 12, 2015.
Intuitive Surgical fell 1.9%
On October 12, Intuitive Surgical (ISRG) fell by ~1.9% on profit booking. The stock closed at $460.84 and was trading below its 20-day, 50-day, and 100-day moving averages. The stock saw high trading volumes of ~384,000 shares as compared to its five-day average trading volume of ~275,000 shares per day. The 14-day RSI (relative strength index) stood at 36, indicating that the stock is neither overbought nor oversold. ISRG has a weight of 3.6% in IHI’s portfolio.
On the other hand, St. Jude Medical (STJ) rose 2.2% on the news that it received CE Mark’s approval for its HeartMate product. STJ closed at $65.39 and was trading above its 20-day moving average, but below its 50-day and 100-day moving averages. The stock’s 14-day RSI (relative strength index) stood at 48, indicating the stock is neither overbought nor oversold. At its current market price, STJ is trading at 17.4x of its trailing-12-month price-to-equity multiple. The stock’s price-to-book value (or PVB) stood at 4.8x. STJ makes up 3.7% of IHI’s portfolio.
Continue to Next Part Browse this series on Market Realist:
|
|
| |
ProfileMarket IndicatorsVALUE : Projects & res.Press releasesAnnual reportRISK : Asset profileContact Cpy |
Thermo Fisher is based in United states of america. Thermo Fisher is listed in United States of America. Its market capitalisation is US$ 224.4 billions as of today (€ 209.7 billions). Its stock quote reached its lowest recent point on November 15, 2013 at US$ 100.01, and its highest recent level on April 26, 2024 at US$ 573.60. Thermo Fisher has 391 220 000 shares outstanding. |